摘要 |
A method is provided for treating a patient with a medical condition that involves angiogenesis or HIF-1 overexpression with a compound having the structure of formula (I) wherein Z, x, y, and R<SUP>1 </SUP>through R<SUP>11 </SUP>are as defined herein.
|